Crohn’s study found no reason to continue immunomodulators after starting anti-TNFs

Baseline exposure to an immunomodulator did not improve the odds of clinical response or remission when starting anti–tumor necrosis factor (anti-TNF) therapy for Crohn’s disease (CD), said authors...